Pharmafile Logo

Apodi Ltd

Established in 2006 by a group of highly experienced outsourcing business specialists, Apodi provides comprehensive outsourcing solutions to pharmaceutical and healthcare businesses and organisations. We recognise that the business environment for these industry sectors is changing and that there is a need for highly professional, tailored outsourcing services offering a rapid, effective response and delivering the best ROI. Through commercial insight, market intelligence and highly motivated people, Apodi helps our clients achieve improved outcomes and performance. Over the years we have worked hard to break the traditional model with a focus on the changing NHS environment and the challenge we all face to improve patient outcomes.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Company Details

One St Peters Road, Maidenhead, Berks, SL6 7QU, United Kingdom
+44 (0)1628 500 890

 Latest Content from PMHub 

ANTHEM strengthens team with three appointments following Healthy Influence launch

Press Releases | October 19, 2026 | Resonant Group

Healthcare communications consultancy welcomes new talent as it invests in its next phase of growth

Access The Vector Issue 3: 15 payers describe the likely affect of EU General Pharmaceutical Legislation on orphan drug strategy

In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they believe the new EU General Pharmaceutical Legislation will...

Your AI pilot works. That’s the problem.

What breaks when you scale it won't be the model. It'll be your data.

“We’ve been told we can’t touch AI”

It's not been a great few weeks for anyone trying to make the calm, sensible case for AI tools. Researchers have been quitting the big labs, including Anthropic, and going...

What 90 Minutes of Live AI Case Practice Revealed About Physician Readiness

Press Releases | October 12, 2026 | Medscape Education

At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the practical and ethical use of AI. The format was case-based. The faculty presented...

On GLOBE Final Rule

The publication of the GLOBE Final Rule provides important clarity on the administration's approach to MFN pricing and what it could mean for pharmaceutical pricing, reimbursement, and access strategy globally....

Rethinking Prenatal Migraine Management: The Clinical Case for Neuromodulation

Disclaimer: Management of migraine in pregnancy typically combines lifestyle strategies, nonpharmacologic approaches, selected pharmacologic options when benefits outweigh risks, and, increasingly, noninvasive neuromodulation technologies.

Pharma leadership strategies for talent, AI adoption, and continuous learning

In a recent interview with Pharma Exec, Elaine Ferguson, Global President of Inizio Medical, explores how pharma leadership can support talent development, use AI to augment the workforce, encourage continuous...

Invited, but not equipped: patient involvement needs more than an open door

Explore how pharma can help patients and patient organisations prepare for meaningful involvement in EU HTA without shaping their contribution.

Advancing the Frontier of Cancer Care: Medscape’s Mission at ESMO 2026

For more than 30 years, Medscape Education's dedication has been centered on a single goal: building independent, accredited oncology education that improves patient outcomes. This year, at the European Society...